GLP-1 Injection Side Effects: What’s Common, Serious, and Worth Discussing

GLP-1 injections can cause nausea, vomiting, diarrhea, constipation, and stomach discomfort, especially when treatment begins or changes. Semaglutide and tirzepatide have important differences, but both need clinician-guided screening, follow-up, and attention to hydration, other medicines, and serious symptoms.1 2

What side effects can GLP-1 injections cause?

GLP-1 receptor agonists are medicines that act like the natural gut hormone glucagon-like peptide-1. They can affect appetite, blood sugar, and how quickly food leaves the stomach. Digestive symptoms are the most common effects, including nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, and bloating.1 4

The most common digestive side effects

Semaglutide is sold in FDA-approved products including Ozempic and Wegovy. Tirzepatide is sold in FDA-approved products including Mounjaro and Zepbound, but it is a dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist rather than a GLP-1-only medicine.1 2 Both labels list nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion among reported adverse reactions.1 2

• Nausea or an unsettled stomach
• Vomiting or diarrhea
• Constipation and bloating
• Stomach pain, indigestion, or reflux-like discomfort
• Reduced appetite or feeling full sooner than usual

Why side effects may be more noticeable when treatment starts or changes

GLP-1-based medicines slow gastric emptying, meaning food may move more slowly from the stomach into the small intestine. That mechanism can contribute to fullness and digestive symptoms. FDA-approved labels use gradual dose escalation to reduce gastrointestinal side effects, but an individual prescriber decides whether and how treatment should change.1 2

Side effects can affect whether a person continues treatment, which is one reason to report symptoms instead of changing a prescription on your own.3 For a broader overview, see our guide to GLP-1 side effects.

Can GLP-1 injections cause constipation, fatigue, or dehydration?

Yes. Constipation and dehydration can occur with GLP-1-based treatment, particularly if nausea, vomiting, diarrhea, or reduced fluid intake are also present. Fatigue is less specific: it can have many causes and should not automatically be assumed to be a direct medicine effect.1 2

Constipation and slower digestion

Constipation is listed in the FDA prescribing information for semaglutide and tirzepatide products. Slower stomach emptying may be part of the picture, but constipation can also relate to lower food intake, lower fluid intake, diet changes, other medicines, and an underlying health condition.1 2

Fatigue: possible contributing factors to discuss with a clinician

Feeling tired can occur alongside poor intake, dehydration, vomiting, diarrhea, sleep disruption, or changes in blood sugar. It may also reflect a separate medical issue. A clinician can help assess the timing, severity, food and fluid intake, blood-sugar medicines, and other possible causes rather than treating fatigue as a proven direct GLP-1 effect.1 2

Vomiting, diarrhea, and dehydration concerns

Repeated vomiting or diarrhea can lead to fluid loss. FDA labels warn that gastrointestinal reactions can be severe and that volume depletion may contribute to acute kidney injury in some people.1 2 Contact a clinician promptly if you cannot keep fluids down, urinate much less than usual, feel faint, or have persistent vomiting or diarrhea.

Which GLP-1 injection side effects are serious?

Most digestive symptoms are mild to moderate, but severe or persistent symptoms need prompt evaluation. FDA labels for semaglutide and tirzepatide include warnings about pancreatitis, gallbladder disease, kidney problems related to dehydration, serious allergic reactions, and low blood sugar when used with certain diabetes medicines.1 2

Severe or persistent abdominal symptoms

Seek prompt medical advice for severe abdominal pain that does not go away, especially if it may spread to the back or occurs with vomiting. Acute pancreatitis is an important warning in the FDA labeling for both semaglutide and tirzepatide products.1 2 Gallbladder problems can also cause upper abdominal pain, fever, yellowing of the skin or eyes, or pale stools.1 2

Symptoms that may need urgent evaluation

• Severe, persistent abdominal pain or abdominal pain with repeated vomiting
• Vomiting that prevents you from keeping down fluids
• Fainting, confusion, marked weakness, or signs of dehydration
• Swelling of the face, lips, tongue, or throat; trouble breathing; or widespread hives
• Symptoms of low blood sugar, such as shaking, sweating, confusion, fast heartbeat, or dizziness, especially when insulin or a sulfonylurea is also used1 2

Eye symptoms, gallbladder symptoms, and procedures involving anesthesia

People with type 2 diabetes and a history of diabetic retinopathy should discuss eye monitoring with their clinician. Rapid improvement in glucose control has been associated with temporary worsening of diabetic retinopathy in some settings, and semaglutide labeling specifically addresses this concern.1 Report new vision changes promptly.

Tell your surgical, anesthesia, dental-sedation, or endoscopy team about GLP-1 treatment well before a procedure. Because these medicines can delay stomach emptying, retained stomach contents may increase aspiration risk during anesthesia or deep sedation; professional guidance recommends an individualized risk assessment rather than a one-size-fits-all plan.3 Procedure planning should begin before the scheduled date.

Are semaglutide and tirzepatide side effects the same?

They overlap substantially, especially for gastrointestinal effects, but they are not identical medicines. Both can cause nausea, vomiting, diarrhea, constipation, and abdominal discomfort, while their receptor activity, approved uses, labeling details, and an individual’s experience can differ.1 2

Semaglutide: Ozempic and Wegovy

Semaglutide is a GLP-1 receptor agonist. Ozempic is FDA-approved for type 2 diabetes, while Wegovy is FDA-approved for chronic weight management in certain patients and for reducing cardiovascular risk in certain adults with cardiovascular disease and overweight or obesity.1 Its label includes gastrointestinal effects, pancreatitis and gallbladder warnings, kidney-related concerns during volume depletion, and a boxed warning related to thyroid C-cell tumors observed in rodents.1

Tirzepatide: Mounjaro and Zepbound

Tirzepatide activates both GIP and GLP-1 receptors. Mounjaro is FDA-approved for type 2 diabetes, and Zepbound is FDA-approved for chronic weight management in certain patients and for obstructive sleep apnea in certain adults with obesity.2 Its label also describes gastrointestinal adverse effects and warnings including pancreatitis, gallbladder disease, dehydration-related kidney injury, hypoglycemia with insulin or sulfonylureas, and thyroid C-cell tumors observed in rodents.2

GLP-1 receptor agonists versus dual GIP/GLP-1 receptor agonists

Clinical trial results for FDA-approved semaglutide and tirzepatide products cannot be assumed for compounded formulations. Compounded drugs are not FDA-approved, and FDA has not evaluated compounded semaglutide or compounded tirzepatide for safety, effectiveness, or equivalence to branded products.

What medicines and situations should be reviewed before using a GLP-1 injection?

A clinician should review your complete medication list, health history, and upcoming procedures before prescribing. Insulin and sulfonylureas need special attention because using them with semaglutide or tirzepatide can increase the risk of hypoglycemia.1 2

Why insulin and sulfonylureas require special clinical review

GLP-1-based medicines alone have a lower hypoglycemia risk than insulin or sulfonylureas, but the risk rises when these medicines are combined. Prescribers may need to review a person’s broader diabetes plan and glucose-monitoring needs.1 2

Other medicines, supplements, and delayed stomach emptying

Delayed stomach emptying may affect how quickly some oral medicines are absorbed. Tell the prescribing clinician about every prescription medicine, over-the-counter product, vitamin, and supplement, especially medicines that need a reliable effect or have a narrow safety margin.1 2 Do not start, stop, or combine prescription medicines based on an article alone.

Surgery, anesthesia, and endoscopy planning

For planned procedures, share the name of your medicine, your dosing schedule, and whether you have active digestive symptoms with the procedure team. Multi-society guidance emphasizes that the plan should account for symptoms and individual aspiration risk.3

How can patients track side effects and discuss them with a clinician?

A clear symptom record helps a clinician see patterns and decide what needs attention. Track symptoms from the first week onward, particularly after any provider-directed treatment change, and share the record through the care channel your prescriber uses.1 2

What to record between visits

• The symptom, when it began, and how long it lasts
• Whether vomiting, diarrhea, constipation, or abdominal pain is affecting food or fluid intake
• Any dizziness, fainting, reduced urination, or signs of low blood sugar
• All medicines and supplements taken that day
• Upcoming surgery, anesthesia, sedation, dental procedures, or endoscopy

When not to wait for a routine appointment

Do not wait for a routine message if symptoms are severe, rapidly worsening, or include trouble breathing, severe persistent abdominal pain, repeated vomiting, confusion, fainting, or possible dehydration. Seek urgent care or emergency evaluation as appropriate. For a suspected overdose or medication error, contact Poison Help at 1-800-222-1222 in the United States.5

Nutrition and hydration can also be harder when nausea or early fullness is present. Our guide to what to eat on GLP-1 medication covers general food and fluid considerations to discuss with your care team.

How does Chia approach GLP-1 injection safety and follow-up?

At Chia, treatment starts with an online clinical review, not an automatic prescription. You complete a health questionnaire, and a licensed US provider reviews your history, current medicines, symptoms, and eligibility before deciding whether treatment is clinically appropriate. A prescription is never guaranteed.

Clinician review, eligibility, and provider-guided adjustments

If treatment is prescribed, dosing and any adjustments are provider-guided. Microdosing is not an FDA-labeled dosing approach, and compounded medications are not FDA-approved. Microdosing plans are available for semaglutide and tirzepatide when a Chia provider determines that approach is appropriate.

Compounded semaglutide and compounded tirzepatide through state-licensed 503A pharmacies

Chia offers compounded semaglutide injections and compounded tirzepatide injections, supplied by US state-licensed 503A compounding pharmacies and shipped to the patient’s door. Compounded medications are not FDA-approved and should not be described as equivalent to or interchangeable with Ozempic, Wegovy, Mounjaro, or Zepbound.

Chia GLP-1 options: semaglutide injections and tirzepatide injections

When a patient may use the eligibility quiz or DoctorMCP to begin a clinician-reviewed request

If you want to explore whether treatment may fit your goals, you can use Chia’s eligibility quiz. AI agents can also reach Chia through DoctorMCP at mcp.chia.health to help begin a clinician-reviewed request. Neither route replaces a medical evaluation, and neither guarantees a prescription.

For more medication-specific education, read our overview of tirzepatide weight-loss injections and our guide to semaglutide dosing and side effects.

Frequently asked questions about GLP-1 injection side effects

What is the bottom line on GLP-1 injection side effects?

GLP-1 injections can be associated with meaningful digestive side effects, and most concerns deserve a conversation rather than self-directed medication changes. Prompt action matters when symptoms are severe or persistent. A licensed clinician can help weigh symptoms, medication interactions, hydration, diabetes medicines, and procedure plans using your individual history.1 2 3

Keep reading

Weight Management

GLP-1 Weight Loss Clinics: How to Compare Safety, Cost, and Access

Weight Management

Cheap Weight Loss Injections: What GLP-1s Really Cost With and Without Insurance

Weight Management

Cheapest Online Weight Loss Programs: How to Compare Cost, Care, and Safety